Showing results 4 to 8 of 8
< previous
| Preview | Issue Date | Title / Name | Author(s) | Type |
| 31-May-2023 | Real world evidence of systemic therapy in hormone receptor positive advanced breast cancer (HR+ ABC) in Australia: ARORA Registry. | Wen Lok, Sheau; Tung, Iris; Anton, Angelyn; Baron-Hay, Sally; De Boer, Richard H., et al | Conference Paper | |
 | 29-May-2024 | Real world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer. | Wong, Vanessa; Loft, Matthew; Kosmider, Suzanne; Wong, Rachel; Shspiro, Jeremy David, et al | Conference Paper | |
| Jan-2025 | Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer | Loft, Matthew; Wong, Vanessa; Kosminder, Suzanne; Wong, Rachel; Shapiro, Jeremy, et al | Journal Article | |
| 18-Nov-2024 | Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer | Loft, Matthew; Wong, Vanessa; Kosmider, Suzanne; Wong, Rachel; Shapiro, Jeremy, et al | Journal Article | |
| 30-Jul-2026 | Real-world outcomes in patients with hormone receptor positive, human epidermal growth factor receptor 2 receptor-negative advanced breast cancer and visceral metastases at baseline – advanced hormone receptor positive breast cancer registry in Australia | Wigston, Lucas; Morris, Ali; Wen Lok, Sheau; Baron-Hay, Sally; de Boer, Richard, et al | Journal Article | |